The international elite of the cannabis industry gathers at Cannabis Summit 2025 in the World Horti Center, Netherlands—an event carefully curated to bring together the most important developments in the sector. This gathering marks the perfect kickoff for a series of groundbreaking events in the coming weeks. In particular, ICBC Barcelona is set to play […]
For the first time, the National Council’s health policy makers are outlining just how liberal the state should be with THC products in the future. Meanwhile, Germany is heading in a completely different direction? Today, it’s election day. Meanwhile in Switzerland, Jamie Pearson in CannabisNow gave us a huge inspiration for this article here and
There’s a gold rush atmosphere in the cannabis industry: Investors are meeting in Zurich Read More »
On February 12, 2025, Brazil’s Superior Court of Justice (STJ) rejected a request to delay the deadlines for regulating the cultivation of industrial hemp for medicinal purposes. This ruling comes in the wake of a major decision from November 2024, when the court’s First Section authorized the cultivation of low-Tetrahydrocannabinol (THC) hemp – a variety
Brazil’s Superior Court of Justice Rejects Postponement of Cannabis Regulation Deadlines Read More »
The recent UK parliamentary debate on medical cannabis under the new Labour administration has been a major disappointment for advocates and investors hoping for reform. Despite a chorus of voices from multiple parties calling for an overhaul of the UK’s outdated regulatory framework, the government has once again reverted to its well-worn stance, emphasizing the
The cannabis rescheduling debate in the United States has reached a critical juncture, marked by the recent appointment of Derek Maltz as interim administrator of the U.S. Drug Enforcement Administration (DEA). Maltz, a career DEA official and former chief of the New York Drug Enforcement Task Force, has expressed skepticism about the ongoing process to
Cannabis Rescheduling Debate in America: A Nation Divided! Read More »
The cannabis industry in the United States finds itself at a critical crossroads. While legislative progress continues to inch forward and the market matures, fundamental challenges like high taxation, overleveraged businesses, and investor skepticism threaten to hinder growth. As the industry gathers for MJBizCon, it’s an opportune moment to discuss the pressing realities and untapped
As cannabis policies evolve across Europe, a new era of collaboration is shaping the continent’s approach to regulating non-medical cannabis. In Berlin, ministerial representatives, experts, and civil society stakeholders from countries such as Luxembourg, Malta, the Netherlands, Czech Republic, Switzerland, and Germany convened to discuss the future of cannabis regulation. Hosted by Germany’s Federal Commissioner
The Future of Cannabis in Europe: Collaboration, Regulation, and Innovation Read More »
As Poland inches closer to a landmark decision on cannabis policy, the country finds itself navigating two transformative paths: decriminalization of recreational cannabis and scaling its booming medical cannabis market. With a proposal to decriminalize cannabis possession and cultivation awaiting Prime Minister Donald Tusk’s response, and medical cannabis imports soaring to unprecedented levels, Poland’s cannabis
The Countdown Begins: Will Poland Choose Decriminalization or Medical Market Growth? Read More »
A week ago, the U.S. elected a new president, and at the same time, Germany faces political turbulence: Chancellor Olaf Scholz plans to call a vote of confidence in mid-January. “Business as usual,” one might think—but not quite. As an investor, I’ve learned not to rely on governments, but I did expect a bit more
When the UK rescheduled cannabis six years ago, it marked a historic turning point—a beacon of hope for patients in need and a gateway for cannabis entrepreneurs. Despite this milestone, the journey toward effective patient access remains fraught with obstacles, particularly within the public sector. A recent report from the Cannabis Industry Council (CIC) highlights
Six Years After Legalization: NHS Still Failing to Provide Access to Medical Cannabis Read More »
